0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Detection Methods Environmental Sources Food & Water Human Health Effects Marine & Wildlife Nanoplastics Policy & Risk Remediation Reproductive & Development Sign in to save

Microplastics as an Emerging Human Health Risk: Mechanisms, Exposure, and Clinical Evidence

Zenodo (CERN European Organization for Nuclear Research) 2026 Score: 50 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Dr Asif Rasheed, Hadiqa Bushra Awesi, Farzeen Ajmal Younus

Summary

This review examines the growing body of evidence on how microplastics enter the human body through ingestion, inhalation, and skin contact, and have now been detected in blood, lung tissue, placenta, and cardiovascular tissue. Evidence indicates that microplastics may cause harm through oxidative stress, inflammation, and cellular damage, though a direct causal link to specific health conditions has not yet been fully established.

Microplastics (MPs) refer to plastic particles <5 mm in size, have gained growing attention pervasive across environmental compartments such as air, soil, and aquatic systems. Human exposure primarily occurs via ingestion, inhalation, and dermal contact with MPs now detected in various biological specimens such as blood, placenta, lung tissue, and cardiovascular tissue. Evidence indicates that MPs can move across biological membranes, undergo systemic distribution, and build up within tissues, raising concern for organ-specific toxicity. Mechanisms implicated in microplastic-induced pathology include oxidative stress, inflammation, epithelial barrier disruption, cellular injury, mitochondrial dysfunction, autophagy dysregulation, and thrombogenic effects. Emerging clinical observations link microplastic burden with cardiovascular disease severity, respiratory disorders, and inflammatory conditions, though causality remains incompletely defined. Advances in detection methodologies, including microscopy, spectroscopy, and mass spectrometric techniques, have supported identification and characterization of MPs in human samples. Prevention strategies focus on reducing plastic use, modifying dietary and personal habits, and improving water treatment and filtration systems. Overall, the growing evidence underscores microplastics as a pressing environmental health concern requiring further mechanistic, epidemiological, and regulatory investigation. Keywords: Microplastics; Human health; Exposure pathways; Cardiovascular toxicity; Respiratory toxicity; Oxidative stress; Autophagy; Inflammation; Nanoplastics

Sign in to start a discussion.

More Papers Like This

Article Tier 2

Microplastics as an Emerging Human Health Risk: Mechanisms, Exposure, and Clinical Evidence

This review examines the growing body of evidence on how microplastics enter the human body through ingestion, inhalation, and skin contact, and have now been detected in blood, lung tissue, placenta, and cardiovascular tissue. Evidence indicates that microplastics may cause harm through oxidative stress, inflammation, and cellular damage, though a direct causal link to specific health conditions has not yet been fully established.

Article Tier 2

The Impact of Microplastic on Human Health

This review synthesized evidence on microplastic exposure pathways and health effects in humans, finding that microplastics enter the body via ingestion, inhalation, and dermal contact and are associated with oxidative stress, inflammation, genotoxicity, and endocrine disruption.

Article Tier 2

Mechanistic insight into potential toxic effects of microplastics and nanoplastics on human health

This review summarizes how microplastics and nanoplastics enter the body through breathing, eating, and skin contact, then travel through the bloodstream to deposit in organs. Studies show they can cause oxidative stress, inflammation, immune dysfunction, genetic damage, developmental abnormalities, and potentially cancer, though most evidence comes from cell and animal studies rather than human research.

Review Tier 2

A review on microplastics and nanoplastics in the environment: Their occurrence, exposure routes, toxic studies, and potential effects on human health

This review summarizes what is known about how microplastics and nanoplastics enter the human body through food, air, and skin contact, and what they do once inside. Studies on cells and animals show these tiny particles can cause oxidative stress, DNA damage, inflammation, and harm to the immune, digestive, reproductive, and nervous systems. The research makes clear that microplastics are not just an environmental problem but a direct concern for human health.

Article Tier 2

Impact of microplastics and nanoplastics on human health: Mechanistic insights and exposure pathways

This review examines how microplastics and nanoplastics enter the human body through ingestion, inhalation, and skin contact, and deposit in tissues including the lungs, kidneys, and gastrointestinal tract. Evidence indicates these particles can cross embryonic layers and reach the placenta, and may cause inflammation, oxidative stress, metabolic disruptions, and immune system effects upon interaction with biological tissues.

Share this paper